UTMB highlights infectious disease experts in ebola fight
Thomas Geisbert and Thomas Ksiazek, two experts with UTMB, have more than 50 years of experience working with infectious diseases between them.
Geisbert has been researching the ebola virus for more than 25 years, including some with the U.S. Army Medical Research Institute of Infectious Diseases in Maryland. Geisbert recently received a $26 million grant from the National Institutes of Health to continue work on vaccines for ebola and the Marburg virus.
Ksiazek led outbreak responses around the world since the 1970s as the head of the Special Pathogens unit at the Centers for Disease Control and Prevention. He is departing this month to lead the CDC team on the ground in Sierra Leone to battle the ebola outbreak.
The ebola research at UTMB is made possible by the Galveston National Laboratory, which is the only operational Biosafety Level Four lab on a U.S. academic campus.
The work is aided by the capabilities of the Sealy Center for Vaccine Development, whose researchers are investigating new ways to treat infectious diseases of all kinds.